Francesco Costa

Francesco Costa

Interventional cardiologist / Cardiologist
Virgen de la Victoria University Hospital Emergency Room - Málaga, Spain

Member of the Editorial Team, PCRonline Editorial Board

Declaration of interest

FunctionCompany
None

Latest contributions

AI in imaging & the cathlab - opportunities in procedural planning & guidance

20 May 2026 – From EuroPCR 2026

This session explores the role of artificial intelligence in imaging and the cathlab, emphasizing computer vision applications distinct from language models. It discusses AI's integration into procedural planning and guidance, balancing algorithmic support with physician judgement to enhance interventional cardiology workflows.

When ECMO is used in complex pulmonary embolism

19 May 2026 – From EuroPCR 2026

Examine the critical role of extracorporeal membrane oxygenation (ECMO) in managing complex pulmonary embolism cases. This session covers ECMO-supported interventions for central pulmonary artery occlusions, combined treatments including thrombectomy, and unique cases such as right atrial thrombus complications and pioneering ECMO-supported thrombo-embolectomy procedures.

Can’t stand heavy metal: how to treat an ACS with severe metal allergy?

17 Mar 2025

Francesco Costa

Author

Francesco Costa

Author

Antonio Muñoz Garcia
Alberto Piserra

Author

Alberto Piserra

Author

Juan Horacio Alonso Briales

No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial

04 Apr 2022

Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.

Francesco Costa

Author

Francesco Costa

PCRonline @ ACC 2022 Scientific Sessions

29 Mar 2022

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Francesco Costa

Author

Francesco Costa

PCRonline @ TCT 2021 - Get the international perspective!

03 Nov 2021

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!